Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Pharma
Merck KGaA jumps back into M&A game with $3.9B SpringWorks buyout
Merck KGaA’s long courtship of SpringWorks Therapeutics has come to fruition as the German drugmaker has bought it out for $3.9 billion.
Kevin Dunleavy
Apr 28, 2025 11:09am
Merck KGaA confirms talks with SpringWorks about $3.5B buyout
Apr 25, 2025 8:12am
Thera juggles multiple suitors, including $255M offer from CDMO
Apr 14, 2025 7:45am
Bluebird bio receives rival M&A bid worth 50% higher
Mar 28, 2025 7:14pm
Klick buys Ward6 Singapore’s operations to fuel Asian expansion
Mar 17, 2025 6:00pm
BMS buys cell therapy partner 2seventy bio for $286M
Mar 11, 2025 10:12am
